Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
OPERATING ACTIVITIES:
Net income	$ 278	$ 189
Adjustments to net income:
Depreciation and amortization	312	273
Gain on disposal and sale of business interests	(43)	0
Impairment expense	46	20
Deferred income tax expense (benefit)	222	(11)
Emissions Allowance Expense	47	89
Other	104	89
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(232)	(62)
(Increase) decrease in inventory	72	191
(Increase) decrease in prepaid expenses and other current assets	39	64
(Increase) decrease in other assets	(91)	50
Increase (decrease) in accounts payable and other current liabilities	(85)	(293)
Increase (decrease) in income tax payables, net and other tax payables	(327)	(7)
Increase (decrease) in deferred income	23	21
Increase (decrease) in other liabilities	(5)	45
Net cash provided by operating activities	287	625
INVESTING ACTIVITIES:
Capital expenditures	(2,148)	(1,551)
Payments to Acquire Businesses and Interest in Affiliates	57	0
Proceeds from Divestiture of Businesses and Interests in Affiliates	11	98
Sale of short-term investments	141	356
Purchase of short-term investments	(144)	(418)
Contributions and loans to equity affiliates	(21)	(20)
Payments to Acquire Intangible Assets	(56)	(78)
Other investing	(112)	(11)
Net cash used in investing activities	(2,386)	(1,624)
FINANCING ACTIVITIES:
Borrowings under the revolving credit facilities	1,741	1,415
Repayments under the revolving credit facilities	(1,037)	(1,055)
Proceeds from (Repayments of) Commercial Paper	719	350
Issuance of recourse debt	0	500
Issuance of non-recourse debt	2,131	690
Repayments of non-recourse debt	(915)	(660)
Payments for financing fees	(31)	(18)
Purchases under supplier financing arrangements	(486)	(529)
Repayments of obligations under supplier financing arrangements	516	587
Distributions to noncontrolling interests	(23)	(47)
Contributions from noncontrolling interests	26	18
Sales to Noncontrolling Interests	125	0
Dividends paid on AES common stock	(116)	(111)
Payments for financed capital expenditures	(7)	(4)
Other financing	23	(4)
Net cash provided by financing activities	2,606	1,016
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(15)	(18)
Net Cash Change Of Discontinued And Held For Sale Businesses	73	(9)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	565	(10)
Cash, cash equivalents and restricted cash, beginning	1,990	2,087
Cash, cash equivalents and restricted cash, ending	2,555	2,077
SUPPLEMENTAL DISCLOSURES:
Cash payments for interest, net of amounts capitalized	354	252
Cash payments for income taxes, net of refunds	68	53
SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Noncash or Part Noncash Divestiture, Amount of Consideration Received	9	0
Lease Obligation Incurred	124	19
Conversion of Stock, Amount Converted	838	0
Dividends declared but not yet paid	116	111
Other current assets, net of allowance of $15 and $14, respectively	1,404
Loss (gain) on realized/unrealized derivatives	$ (73)	$ (33)